Boehringer Offers Fixes To Clear Sanofi Deal In EU
Pharmaceutical company Boehringer Ingelheim has offered remedies to the European Commission to alleviate competition concerns over a deal in which it would acquire Sanofi's animal health business Merial in exchange for...To view the full article, register now.
Already a subscriber? Click here to view full article